Amphomycin (cas 1402-82-0) inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus☆

Add time:09/04/2019    Source:sciencedirect.com

Amphomycin (cas 1402-82-0), a selective inhibitor of peptidoglycan synthesis of bacteria, inhibited the lipid intermediates accumulation and the peptidoglycan synthesis from UDP-N-acetylmuramyl-L-Ala-D-Glu-[3H]-meso-Dpm-D-Ala-D-Ala (UDP-MurNAc-pentapeptide) and UDP-N-acetylglucosamine (UDP-GlcNAc) with a particulate fraction from Bacillusmegaterium KM, and also inhibited the formation of MurNAc (-pentapeptide)-P-P-lipid in the absence of UDP-GlcNAc. But it did not inhibit the formation of peptidoglycan from MurNAc(-pentapeptide)-P-P-lipid and UDP-GlcNAc with the same system of the organism.Thus, it is concluded that the site of action of amphomycin is phospho-MurNAc-pentapeptide translocase in peptidoglycan synthesis.

We also recommend Trading Suppliers and Manufacturers of Amphomycin (cas 1402-82-0). Pls Click Website Link as below: cas 1402-82-0 suppliers

Prev:In vivo and in vitro inhibition of lipid-linked saccharide and glycoprotein synthesis in plants by Amphomycin (cas 1402-82-0)
Next:Incorporation of glucose into lipid-linked saccharides in aorta and its inhibition by Amphomycin (cas 1402-82-0))